
Godavari Drugs (GODAVARI) Share Price Rises 11.39% to Rs 131.05
Updated: 8 Oct 2026 • 11:24 am
Posted by:

Godavari Drugs Share Price is trading at Rs 131.05, up 11.39% from the previous close, with market capitalisation at Rs 128.4 Cr. The move places Godavari Drugs Share Price in focus in today’s stock news because the session has already shown a wide intraday range, even though a company-specific catalyst is not established. According to Univest data, the price event is confirmed, but no company-specific catalyst is established. For readers tracking Godavari Drugs Share Price Today, the key question is not only the percentage move but also how that move compares with the company’s valuation, profitability ratios and healthcare-sector benchmarks. Univest is useful here because it helps separate a price rise from the fundamental context behind it. The latest Univest figures show a stock that has moved decisively higher, while the next checkpoints remain the current range, valuation ratios and peer positioning.
Godavari Drugs Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 131.05 |
| Previous Close | Rs 117.65 |
| Today's Move | Rs 13.4 (+11.39%) |
| Open | Rs 118.6 |
| High | Rs 134 |
| Low | Rs 118 |
| Market Capitalisation | Rs 128.4 crore |
| Market Cap Category | Micro Cap |
Godavari Drugs Ltd. (GODAVARI) rose to Rs 131.05 from the previous close of Rs 117.65, a move of Rs 13.4 or 11.39%. The stock opened at Rs 118.6, reached a high of Rs 134, recorded a low of Rs 118.
Godavari Drugs Share Price rose from Rs 117.65 to Rs 131.05, adding Rs 13.40 or 11.39% in today’s trade. The stock opened at Rs 118.60, touched a high of Rs 134 and a low of Rs 118, which shows that Godavari Drugs Share Price Today has already moved well beyond the opening level. This is a clean price rise story rather than a commentary on catalysts. For anyone scanning Godavari Drugs Share Price Live, the numbers confirm a sharp share price gain against the previous close, with the current price sitting near the upper end of the day’s range. Univest data also shows that the move has arrived alongside a modest market capitalisation base of Rs 128.4 Cr, which keeps the stock in a distinct risk-return bracket within today’s market update. That price action leads directly into Godavari Drugs Fundamental Analysis.
Godavari Drugs Ltd. (GODAVARI) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 128.4 crore |
| P/E Ratio | 30.9x |
| P/B Ratio | 1.63x |
| ROE | 10.64% |
| ROCE | 10.13% |
| EPS | Rs 3.81 |
| Book Value Per Share | Rs 72.07 |
| Dividend Yield | 0% |
Godavari Drugs Ltd. (GODAVARI) fundamental metrics show P/E 30.9x, P/B 1.63x, ROE 10.64%, ROCE 10.13%. These figures provide context only and are not a buy or sell signal.
Godavari Drugs Ltd. has a market capitalisation of Rs 128.4 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 30.9x, P/B at 1.63x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 10.64% and ROCE of 10.13%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 3.81, book value per share of Rs 72.07, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.87x, median ROE of 11.61%, median ROCE of 13.46%. Taken together, they outline the fundamentals rather than a view on the stock.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 30.9x |
| Benchmark Median P/E | 31.87x |
| Benchmark Average P/E | 48.48x |
| Benchmark P/E Range | 3.58x to 708.87x |
| Company P/B Ratio | 1.63x |
| Benchmark Median P/B | 2.98x |
| Company ROE | 10.64% |
| Benchmark Median ROE | 11.61% |
| Company ROCE | 10.13% |
| Benchmark Median ROCE | 13.46% |
| Company Market Capitalisation | Rs 128.4 crore |
| Benchmark Median Market Cap | Rs 854.81 crore |
Godavari Drugs Ltd. (GODAVARI) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Godavari Drugs Ltd. (GODAVARI) has a P/E ratio of 30.9x, which is below the benchmark median of 31.87x, a difference of -3.04%. On its own, the P/E gap is a valuation reference point, not a trading call.
Godavari Drugs Ltd. (GODAVARI) has a ROE of 10.64%, which is below the benchmark median of 11.61%, a difference of -8.35%. Godavari Drugs Ltd. (GODAVARI) has a ROCE of 10.13%, which is below the benchmark median of 13.46%, a difference of -24.74%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,32,120.23 | 35.37 | 4.95 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,53,389.76 | 86.95 | 14.4 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,81,739.76 | 82.14 | 19.96 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,15,710.44 | 25.51 | 4.27 | 19.69 | 21.39 |
| Laurus Labs Ltd. | LAURUSLABS | 1,10,980.13 | 101.55 | 19.69 | 18.31 | 18.2 |
Godavari Drugs Ltd. (GODAVARI) has a P/E ratio of 30.9x compared with the displayed peer median of 82.14x. This peer read is a relative benchmark rather than a trading signal. Its ROE of 10.64% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 10.13% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Godavari Drugs Ltd. (GODAVARI) has a market capitalisation of Rs 128.4 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Godavari Drugs
- Godavari Drugs Share Price is trading 11.39% higher today, so the intraday price rise is the first point of attention.
- Godavari Drugs Share Price Today is near the top of its day’s range, with a high of Rs 134 and a low of Rs 118.
- Godavari Drugs Fundamental Analysis shows P/E of 30.9, P/B of 1.63, ROE of 10.64% and ROCE of 10.13%.
- Godavari Drugs Market Cap at Rs 128.4 Cr places it well below the benchmark industry median.
- Godavari Drugs Share Price also stands out because its valuation is lower than many peer multiples in the same healthcare set.
About Godavari Drugs
Godavari Drugs Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. Godavari Drugs Share Price reflects a business that belongs to a sector where valuation, capital efficiency and scale often differ sharply across listed companies. The company’s profile, as read through Univest data, is centred on its market presence as a smaller listed pharmaceutical name rather than a large diversified healthcare franchise.
For investors checking Godavari Drugs Company News, the important business context is that the stock sits in an industry benchmark with 199 companies, which gives useful comparison depth. Godavari Drugs Share Price therefore has to be viewed alongside market capitalisation, P/E, P/B, ROE and ROCE rather than in isolation. The latest Univest figures suggest that the company is part of a broad pharmaceutical universe where different companies can trade on very different earnings and book-value multiples. That is why Godavari Drugs Stock Analysis usually begins with valuation and sector context before moving to any future financial reporting.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is Godavari Drugs Share Price rising today?
Ans. Godavari Drugs Share Price is rising today because the stock is up 11.39% to Rs 131.05. According to Univest data, the price event is confirmed, but no company-specific catalyst is established.
What is Godavari Drugs Share Price Today?
Ans. Godavari Drugs Share Price Today is Rs 131.05, compared with the previous close of Rs 117.65. The move shows an intraday gain of Rs 13.40 and keeps the stock in focus.
What was Godavari Drugs Share Price before the rise?
Ans. Before the rise, Godavari Drugs Share Price was at the previous close of Rs 117.65. The stock opened at Rs 118.60 and later moved to a high of Rs 134 during the session.
What is Godavari Drugs market capitalisation?
Ans. Godavari Drugs has a market capitalisation of Rs 128.4 Cr. That places Godavari Drugs Share Price in a smaller company-size bracket within the healthcare and pharmaceuticals universe. The company operates in the Healthcare sector.
Is Godavari Drugs Share Price expensive on valuation?
Ans. Godavari Drugs Share Price trades at a P/E of 30.9 and P/B of 1.63. Against the same-industry median, the P/E is slightly lower and the P/B is below the benchmark median.
How do ROE and ROCE look for Godavari Drugs?
Ans. Godavari Drugs has ROE of 10.64% and ROCE of 10.13%. Those figures give basic profitability context, though both sit below the same-industry benchmark medians in the current sector snapshot.
What does EPS tell investors about Godavari Drugs Share Price?
Ans. EPS for Godavari Drugs is Rs 3.81. EPS shows earnings attributable to each share, so it helps investors compare Godavari Drugs Share Price with its current valuation multiple.
What does book value mean for Godavari Drugs?
Ans. Book value is Rs 72.07 per share for Godavari Drugs. Book value per share shows the accounting net worth behind each share and helps frame Godavari Drugs Share Price against assets.
Track Godavari Drugs Share Price on Univest
Use Godavari Drugs Ltd. (GODAVARI) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Track Godavari Drugs Share Price on Univest for live updates on price, market capitalisation, valuation ratios, 52-week levels and market insights. Godavari Drugs Share Price Today can be monitored together with Godavari Drugs Fundamental Analysis, sector context and peer comparison in one place. Univest helps readers follow Godavari Drugs Stock News with a clear mix of price action and financial context.
Recent Articles

Tata Technologies Share Price Jumps 7% to Rs 704 as FY30 Plan Targets $1.1 to $1.3 Billion Revenue, With JPMorgan's Rs 660 Target Below the Market
19 November 2026

Physicswallah Share Price Target: Motilal Oswal Holds Rs 200 After FY30 Guidance as the Stock Closes 6% Higher at Rs 135.98
19 November 2026

Religare Enterprises (RELIGARE) Share Price Rises 5.09% to Rs 232.25
19 November 2026

Universus Photo Imagings Ltd. Hits Upper Circuit for the 2nd Straight Session on NSE, 19 November 2026
19 November 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Tata Technologies Share Price Jumps 7% to Rs 704 as FY30 Plan Targets $1.1 to $1.3 Billion Revenue, With JPMorgan's Rs 660 Target Below the Market
Physicswallah Share Price Target: Motilal Oswal Holds Rs 200 After FY30 Guidance as the Stock Closes 6% Higher at Rs 135.98
Religare Enterprises (RELIGARE) Share Price Rises 5.09% to Rs 232.25
Universus Photo Imagings Ltd. Hits Upper Circuit for the 2nd Straight Session on NSE, 19 November 2026
HGS (INDIA) LIMITED Hits Upper Circuit on NSE, 19 November 2026

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





